Treanda/Levact(bendamustine) from Teva/Mundipharma/Napp combined with Rituxan/MabThera outperformed the current standard of care in treating Non-Hodgkin's Lymphoma (NHL).In the trial, which...
The purpose of this study is to evaluate the efficacy and safety of ibrutinib given in combination with bendamustine and rituximab in patients 65 years of age or older with newly diagnosed...